Lipopolysaccharide-Deficient Acinetobacter baumannii Shows Altered Signaling through Host Toll-Like Receptors and Increased Susceptibility to the Host Antimicrobial Peptide LL-37

Characterization and sensitivity to antibiotics of bacteria isolated from the lower respiratory tract of ventilated patients hospitalized in intensive care units

(2012) Manuel Medell et al.   Brazilian Journal of Infectious Diseases

Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies

(2012) Y. Cai et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Inhibition of LpxC Protects Mice from Resistant Acinetobacter baumannii by Modulating Inflammation and Enhancing Phagocytosis

(2012) L. Lin et al.   mBio

Insertion Sequence ISAba11Is Involved in Colistin Resistance and Loss of Lipopolysaccharide in Acinetobacter baumannii

(2011) Jennifer H. Moffatt et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Colistin-Resistant, Lipopolysaccharide-Deficient Acinetobacter baumannii Responds to Lipopolysaccharide Loss through Increased Expression of Genes Involved in the Synthesis and Transport of Lipoproteins, Phospholipids, and Poly-β-1,6-N-Acetylglucosamine

(2011) Rebekah Henry et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Rational Design of α-Helical Antimicrobial Peptides to Target Gram-negative Pathogens, Acinetobacter baumannii and Pseudomonas aeruginosa: Utilization of Charge, ‘Specificity Determinants,’ Total Hydrophobicity, Hydrophobe Type and Location as Design Para

(2011) Ziqing Jiang et al.   Chemical Biology & Drug Design

In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii

(2011) X. Vila-Farres et al.   CLINICAL MICROBIOLOGY AND INFECTION

Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09)

(2011) A. C. Gales et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Real-time attack on single Escherichia coli cells by the human antimicrobial peptide LL-37

(2011) K. A. Sochacki et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production

(2010) J. H. Moffatt et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Different surface charge of colistin-susceptible and -resistant Acinetobacter baumannii cells measured with zeta potential as a function of growth phase and colistin treatment

(2010) R. L. Soon et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Do Biofilm Formation and Interactions with Human Cells Explain the Clinical Success of Acinetobacter baumannii?

(2010) Anna de Breij et al.   PLoS One

Therapeutic efficacy of buforin II and rifampin in a rat model of Acinetobacter baumannii sepsis

(2009) Oscar Cirioni et al.   CRITICAL CARE MEDICINE

Selection of colistin-resistant Acinetobacter baumannii isolates in postneurosurgical meningitis in an intensive care unit with high presence of heteroresistance to colistin

(2009) Rodriguez Carlos Hernan et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Two distinct clones of carbapenem-resistant Acinetobacter baumannii isolates from Korean hospitals

(2009) Young Kyoung Park et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

High susceptibility to respiratory Acinetobacter baumannii infection in A/J mice is associated with a delay in early pulmonary recruitment of neutrophils

(2009) Hongyu Qiu et al.   MICROBES AND INFECTION

Acinetobacter baumannii: Emergence of a Successful Pathogen

(2008) A. Y. Peleg et al.   CLINICAL MICROBIOLOGY REVIEWS

Rat Pneumonia and Soft-Tissue Infection Models for the Study of Acinetobacter baumannii Biology

(2008) T. A. Russo et al.   INFECTION AND IMMUNITY

Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization

(2008) Veit Hornung et al.   NATURE IMMUNOLOGY